Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory P Forlenza

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Diabetes Care|January 16, 2020
Randomized Controlled Trial of Mobile Closed-Loop ControlBoris Kovatchev, Stacey M Anderson, Dan Raghinaru, et al.
Diabetes Care|April 5, 2020
Erratum. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care 2020;43:607-615Boris Kovatchev, Stacey M Anderson, Dan Raghinaru, et al.
Diabetes Technology & Therapeutics|January 17, 2019
The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component InteroperabilityStacey M Anderson, Eyal Dassau, Dan Raghinaru, et al.
The New England Journal of Medicine|August 27, 2020
A Randomized Trial of Closed-Loop Control in Children with Type 1 DiabetesMarc D Breton, Lauren G Kanapka, Roy W Beck, et al.
Pediatric Diabetes|April 30, 2025
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their CaregiversKorey K Hood, William H Polonsky, Sarah A MacLeish, et al.
Diabetes Care|December 23, 2020
Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 DiabetesLauren G Kanapka, R Paul Wadwa, Marc D Breton, et al.
The New England Journal of Medicine|October 17, 2019
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 DiabetesSue A Brown, Boris P Kovatchev, Dan Raghinaru, et al.
Diabetes Technology & Therapeutics|April 29, 2026
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 DiabetesHalis K Akturk, Laura M Nally, Rayhan A Lal, et al.
Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Diabetes Care|January 16, 2020
Randomized Controlled Trial of Mobile Closed-Loop ControlBoris Kovatchev, Stacey M Anderson, Dan Raghinaru, et al.
Diabetes Care|April 5, 2020
Erratum. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care 2020;43:607-615Boris Kovatchev, Stacey M Anderson, Dan Raghinaru, et al.
Diabetes Technology & Therapeutics|January 17, 2019
The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component InteroperabilityStacey M Anderson, Eyal Dassau, Dan Raghinaru, et al.
The New England Journal of Medicine|August 27, 2020
A Randomized Trial of Closed-Loop Control in Children with Type 1 DiabetesMarc D Breton, Lauren G Kanapka, Roy W Beck, et al.
Pediatric Diabetes|April 30, 2025
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their CaregiversKorey K Hood, William H Polonsky, Sarah A MacLeish, et al.
Diabetes Care|December 23, 2020
Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 DiabetesLauren G Kanapka, R Paul Wadwa, Marc D Breton, et al.
The New England Journal of Medicine|October 17, 2019
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 DiabetesSue A Brown, Boris P Kovatchev, Dan Raghinaru, et al.
Diabetes Technology & Therapeutics|April 29, 2026
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 DiabetesHalis K Akturk, Laura M Nally, Rayhan A Lal, et al.
Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Pageof 15